The Life Care Center in Kirkland, Washington, had the first known COVID-19 outbreak in a U.S. nursing home. In Massachusetts, one-third of nursing homes now have more than 30 COVID-19 cases.
Jason Redmond/AFP/Getty Images
The government doesn’t know how many people have died of COVID-19, in part because it didn’t require nursing homes to report cases to the CDC. In some states, over half of deaths are in nursing homes.
In the rural South, chronic illnesses are common, the population is older and health care options have been declining as hospitals close. All put the population at higher risk from COVID-19.
AP Photo/Rogelio V. Solis
Southern governors are starting to reopen their economies at the same time COVID-19 cases are spreading through the rural South.
To avoid the high risk COVID-19 poses to older adults with chronic illnesses, many doctors have shifted appointments to telemedicine.
BSIP/Universal Images Group via Getty Images
While COVID-19 raises the risk for people with underlying medical conditions such as diabetes, high blood pressure and COPD, social distancing can make it harder to keep up diets and medication.
To control the coronavirus spread, the U.S. needs to get the most value out of the limited testing capacity it has.
Steve Pfost/Newsday RM via Getty Images
Testing everyone for COVID-19 isn’t realistic in a country the size of the US, but there are ways to design testing systems that can catch most of the cases.
It wasn’t until April 8 that the federal government authorized U.S. pharmacies to begin testing for COVID-19.
Alex Edelman/AFP/Getty Images
As the health care system tries to solve the crisis in care around the coronavirus, pharmacists stand ready to help, but they face limits.
When leaders make public health decisions, such as how long social distancing should be maintained to reduce the coronavirus death toll, they often use mathematical models. The numbers aren’t always as simple as they seem.
Alex Brandon/AP
A lot of numbers are being tossed around about COVID-19 and what to expect in the future. They’re being used to make critical public health decisions, but they aren’t as simple as they appear.
Hospitals have started using albuterol inhalers with coronavirus patients, making the rescue medication harder for asthma patients to find in some areas.
Alan Levine/flickr
Asthma rescue inhalers are in short supply, and asthma sufferers are worried about the risks they face from COVID-19. A doctor answers six key questions.
People have resorted to using scarves and bandanas as face masks to protect against spreading coronavirus. While cloth masks aren’t as effective as surgical masks, research suggests they can limit the spread of droplets.
Jens Schleuter/Getty Images
U.S. health officials flipped their advice and now recommend everyone wear cloth masks in public to reduce the spread of coronavirus to others. Some cities have fines for going without masks.
Pediatric epigenetic clocks have the potential to accurately assess biological age. However, possible applications in law enforcement and immigration raise ethical issues.
The flu shot is a bargain – and people are more likely to get it if they know that.
Alarmed by a rapid spread of Lassa fever, the Nigerian Academy of Science is calling on government to declare a health emergency.
Pius Utomi Ekpei/AFP via Getty Images
Concerned about rising cases and spread of Lassa fever, the Nigerian Academy of Science has called on government to declare it a national health emergency.
Genome sequencing technologies have transformed biological research in many ways, but have had a much smaller effect on the treatment of common diseases.
More than 1 million people in the U.S. are addicted to cocaine.
Orawan Pattarawimonchai/Shutterstock.com
Addiction to cocaine is wildly difficult to conquer. But physicians may soon have a new type of gene therapy for patients that makes the drug less alluring.
SHARP Professor, Vitalities Lab, Centre for Social Research in Health and Social Policy Centre, and the ARC Centre of Excellence for Automated Decision-Making and Society, UNSW Sydney
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne